These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

793 related items for PubMed ID: 19833944

  • 1. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ, Graham SJ.
    Science; 2009 Oct 16; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract] [Full Text] [Related]

  • 2. Patents: a threat to innovation?
    Manocaran M.
    Science; 2010 Jan 01; 327(5961):31-2; author reply 32. PubMed ID: 20044557
    [No Abstract] [Full Text] [Related]

  • 3. Balancing innovation, access, and profits--market exclusivity for biologics.
    Engelberg AB, Kesselheim AS, Avorn J.
    N Engl J Med; 2009 Nov 12; 361(20):1917-9. PubMed ID: 19828525
    [No Abstract] [Full Text] [Related]

  • 4. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN, Shadlen KC, Amin TM.
    Science; 2012 Jul 27; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract] [Full Text] [Related]

  • 5. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE.
    Stanford Law Rev; 2006 Feb 27; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract] [Full Text] [Related]

  • 6. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR.
    Suffolk Univ Law Rev; 2003 Feb 27; 36(3):787-819. PubMed ID: 16493844
    [No Abstract] [Full Text] [Related]

  • 7. Pharmaceutical patent settlements: the antitrust risks.
    Balto DA.
    Food Drug Law J; 2000 Feb 27; 55(3):321-41. PubMed ID: 11824464
    [No Abstract] [Full Text] [Related]

  • 8. Staving off death: a case study of the pharmaceutical industry's strategies to protect blockbuster franchises.
    Gorlin DI.
    Food Drug Law J; 2008 Feb 27; 63(4):823-64. PubMed ID: 19601385
    [No Abstract] [Full Text] [Related]

  • 9. Intellectual property. Drug patents at the Supreme Court.
    Hemphill CS, Sampat B.
    Science; 2013 Mar 22; 339(6126):1386-7. PubMed ID: 23520096
    [No Abstract] [Full Text] [Related]

  • 10. A generic problem.
    Hanauer SB.
    Nat Clin Pract Gastroenterol Hepatol; 2006 Dec 22; 3(12):649. PubMed ID: 17130869
    [No Abstract] [Full Text] [Related]

  • 11. Unsettling drug patent settlements: a framework for presumptive illegality.
    Carrier MA.
    Mich Law Rev; 2009 Oct 22; 108(1):37-80. PubMed ID: 20535881
    [Abstract] [Full Text] [Related]

  • 12. Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity.
    Morag-Sela T, Cohn I, Kowalski TJ, Jarecki-Black J, Clyde-Watson Z.
    Nat Biotechnol; 2004 Dec 22; 22(12):1591-2. PubMed ID: 15583670
    [No Abstract] [Full Text] [Related]

  • 13. IP litigation in China could drive innovation.
    Jia H.
    Nat Biotechnol; 2004 Apr 22; 22(4):368. PubMed ID: 15060539
    [No Abstract] [Full Text] [Related]

  • 14. Drug costs threaten patent protection.
    Cimons M.
    Nat Med; 2003 Jan 22; 9(1):9. PubMed ID: 12514706
    [No Abstract] [Full Text] [Related]

  • 15. Enforcing pharmaceutical and biotech patent rights in China.
    Zhang YP, Deng MM.
    Nat Biotechnol; 2008 Nov 22; 26(11):1235-40. PubMed ID: 18997760
    [No Abstract] [Full Text] [Related]

  • 16. Old drugs, new uses: solving a Hatch-Waxman patent predicament.
    McPhie DC.
    Food Drug Law J; 2004 Nov 22; 59(1):155-68. PubMed ID: 15190929
    [No Abstract] [Full Text] [Related]

  • 17. The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984.
    Lewis RA.
    J Contemp Health Law Policy; 1992 Nov 22; 8():361-78. PubMed ID: 10118987
    [No Abstract] [Full Text] [Related]

  • 18. Patent watch.
    Harrison C.
    Nat Rev Drug Discov; 2013 Jan 22; 12(1):14-5. PubMed ID: 23274462
    [No Abstract] [Full Text] [Related]

  • 19. Intellectual property. Fixing the legal framework for pharmaceutical research.
    Knowles SM.
    Science; 2010 Feb 26; 327(5969):1083-4. PubMed ID: 20150445
    [No Abstract] [Full Text] [Related]

  • 20. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers.
    Soehnge H.
    Food Drug Law J; 2003 Feb 26; 58(1):51-80. PubMed ID: 12739584
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.